What's happening in your 3rd week on Mounjaro?

Are the side effects still normal at week three?

For most people, week three sits right at the tail end of the body's adjustment to tirzepatide. Nausea, burping, looser stools and a reduced appetite for rich or fatty foods are the most commonly reported effects in this window. The NHS tirzepatide page lists these as expected early effects, typically most noticeable in the first days after a new dose or a dose increase — neither of which usually applies at week three, since you're still on the pen you started with.

That timing matters. Because week three involves no new injection from a higher-strength pen, many people find the side effects have already softened compared to days one and two. The gut is adapting to slower gastric emptying, and that adaptation tends to be well underway by now. Not for everyone (some people continue to feel nausea into the third week) but a gradual improvement is what the clinical pattern looks like.

Dehydration is worth watching. If nausea or loose stools have been persistent, staying on top of fluids matters more than usual. Sip water consistently rather than drinking large amounts at once; smaller meals at this stage tend to sit better than large ones. These aren't dosing instructions, just practical notes backed by the NHS guidance on managing side effects.

Is it working if I haven't seen weight change yet?

Three weeks is early. The SURMOUNT-1 trial, which randomised 2,539 adults with obesity over 72 weeks, demonstrated that tirzepatide produces meaningful average weight reduction (around 20–21% at 15 mg) but that outcome unfolds gradually across many months, not in the first few weeks. At week three, some people notice the scales have moved a little; many don't. Both are within normal variation.

What changes first is often appetite rather than the number on the scales. People tend to leave food on the plate they'd previously have finished, feel full faster, or simply stop thinking about food between meals. Those are the early signals that the medicine is doing what it's meant to do. Visible weight change usually follows, but the timeline varies from person to person depending on starting point, activity level, and what they're eating.

If you're curious about how the pattern tends to develop across later weeks, a look at the Mounjaro week-by-week overview puts week three in context alongside what typically happens at weeks five, seven and beyond.

Should I be worried if my appetite hasn't changed much?

Not necessarily, and certainly not yet. The 2.5 mg dose is designed primarily as a tolerability step, its job is to let your body adjust to tirzepatide rather than to deliver the full appetite-suppressing effect. Pronounced appetite reduction is more reliably associated with higher doses, which is why the titration schedule exists. Most people move to 5 mg at the start of their second pen (week five), and the appetite change tends to become clearer from that point.

Week three is also when some people start wondering about cost or what the next steps involve. If that's on your mind, the Mounjaro cost page explains what's typically included in a private prescription and what to look for in a provider.

One practical note on routine: keeping your pen in the fridge door where you'll see it when making breakfast can help with the weekly injection habit, consistency with the injection day matters more than the time of day, but having a visual cue removes one source of anxiety early on.

What should prompt a call to my prescriber at week three?

Most of what happens in week three doesn't require urgent action. But some symptoms do warrant contacting your prescribing team promptly. Severe stomach pain that radiates to the back (particularly with vomiting) needs same-day medical attention; the MHRA issued a Drug Safety Update in January 2026 specifically highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing) also need emergency care.

For anything less urgent (ongoing nausea that's making it hard to eat, uncertainty about whether a symptom is normal, questions about your next dose) your prescriber is the right contact. At nume, aftercare is available seven days a week; if you started treatment through us and have a question, the support team can connect you with a prescriber.

People who haven't yet started treatment and want to understand what the process looks like from the beginning often find the first-week overview a useful starting point. And if week three has gone smoothly and you're looking ahead, week five is when most people encounter their first dose change, with week six typically bringing a clearer sense of how the higher dose is settling in.